Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11383757rdf:typepubmed:Citationlld:pubmed
pubmed-article:11383757lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C0027051lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C0015689lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C1274040lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C0032615lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C0010181lld:lifeskim
pubmed-article:11383757lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:11383757pubmed:issue4lld:pubmed
pubmed-article:11383757pubmed:dateCreated2001-5-31lld:pubmed
pubmed-article:11383757pubmed:abstractTextTo estimate the cost effectiveness of treatment with n-3 polyunsaturated fatty acids (PUFA) for secondary prevention after myocardial infarction (MI).lld:pubmed
pubmed-article:11383757pubmed:languageenglld:pubmed
pubmed-article:11383757pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11383757pubmed:citationSubsetTlld:pubmed
pubmed-article:11383757pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11383757pubmed:statusMEDLINElld:pubmed
pubmed-article:11383757pubmed:issn1170-7690lld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:TognoniGGlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:BrunettiMMlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:ValagussaFFlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:FranzosiM GMGlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:MarchioliRRlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:MarfisiR MRMlld:pubmed
pubmed-article:11383757pubmed:authorpubmed-author:GISSI-Prevenz...lld:pubmed
pubmed-article:11383757pubmed:issnTypePrintlld:pubmed
pubmed-article:11383757pubmed:volume19lld:pubmed
pubmed-article:11383757pubmed:ownerNLMlld:pubmed
pubmed-article:11383757pubmed:authorsCompleteYlld:pubmed
pubmed-article:11383757pubmed:pagination411-20lld:pubmed
pubmed-article:11383757pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:meshHeadingpubmed-meshheading:11383757...lld:pubmed
pubmed-article:11383757pubmed:year2001lld:pubmed
pubmed-article:11383757pubmed:articleTitleCost-effectiveness analysis of n-3 polyunsaturated fatty acids (PUFA) after myocardial infarction: results from Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto (GISSI)-Prevenzione Trial.lld:pubmed
pubmed-article:11383757pubmed:affiliationDepartment of Cardiovascular Research, Istituto di Richerche Farmacologiche Mario Negri, Milano, Italy. franzosi@marionegri.itlld:pubmed
pubmed-article:11383757pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:11383757pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11383757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11383757lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:11383757lld:pubmed